ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
ABBOTT LABORATORIES
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$104.06−0.83 (-0.79%)
Close on Oct 19, 2026
- Market cap
- $181.37B
- P/E (TTM)
- 33.5
- Dividend yield
- 2.31%
Fundamental chart
Pick a measure to chart its full history
$44.33BFY2025, +5.3% a year since FY2011